Food Allergy – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Food Allergy – Drugs In Development, 2024 report and make more profitable business decisions.
Food allergies are immune system reactions to certain proteins in food. Symptoms range from mild itching to severe anaphylaxis, involving difficulty breathing and a drop in blood pressure, which can be life-threatening. Common allergens include peanuts, tree nuts, shellfish, eggs, milk, wheat, and soy. Strict avoidance and preparedness for accidental exposure are crucial. Diagnosis involves tests like skin prick or blood tests, and management typically includes eliminating the allergen, carrying emergency medication (like epinephrine), and vigilant label reading. Seeking medical advice is crucial for proper diagnosis, management, and to create an emergency action plan.
The Food Allergy drugs in development market research report provide comprehensive information on the therapeutics under development for Food Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Food Allergy and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Food Allergy | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 85 molecules, with 76 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Food Allergy therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Food Allergy pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Food Allergy treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Abwiz Bio IncAimmune Therapeutics Inc
ALK-Abello AS
Alladapt Immunotherapeutics Inc
Allakos Inc
Allergy Therapeutics Plc
Allero Therapeutics BV
Amgen Inc
Angany Inc
Aravax Pty Ltd
ARS Pharmaceuticals Inc
AstraZeneca Plc
Auro Vaccines LLC
BioLingus AG
BlueWillow Biologics Inc
Cambridge Allergy Ltd
Centro de Biotecnologia y Genomica de Plantas UPM
ClostraBio Inc
Consortia TX Inc
Cour Pharmaceuticals Development Co Inc
DBV Technologies SA
DC4U BV
DMS Imaging SA
Enterome Bioscience SA
F. Hoffmann-La Roche Ltd
GBC-HpVac SA
General Nutraceutical Technology LLC
GI Biome Inc
IgGenix Inc
Immunomic Therapeutics Inc
Inimmune Corp
InnoUp Farma SL
Intrommune Therapeutics Inc
Johns Hopkins University
Kallyope Inc
Lanier Biotherapeutics Inc
Mabylon AG
MD Healthcare Inc
Moonlight Therapeutics Inc
National Hospital Organization Mie National Hospital
National Jewish Health
Neovacs SA
Nestle Health Science
Network Immunology Inc
Novartis AG
Ondek Pty Ltd
Pareto Bio Inc
Phlaxis
Pleros Therapeutics Inc
Prota Therapeutics Pty Ltd
Revelation Biosciences Inc
Revolo Biotherapeutics Ltd
Sementis Ltd
Shandong Boan Biotechnology Co Ltd
Shimane University
Siolta Therapeutics Inc
Sixal Inc
Stallergenes Greer Ltd
Stanford University
Suzhou Connect Biopharmaceuticals Ltd
The Scripps Research Institute
Ukko Inc
United Biomedical Inc
University of Notre Dame
Vedanta Biosciences Inc
Virtici LLC
Yuhan Corp
Zonhon Biopharma Institute Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Food Allergy reports